Is Quaker Chemical Corporation (KWR) A Smart Long-Term Buy?

Carillon Tower Advisers, an investment management firm, published its fourth quarter 2020 “Carillon Eagle Small Cap Growth Fund” investor letter – a copy of which can be downloaded here. In the letter, the fund talked about their best and worst securities, together with their outlook for this year from an investment perspective. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.

Carillon Eagle Small Cap Growth Fund, in their Q4 2020 investor letter, mentioned Quaker Chemical Corporation (NYSE: KWR) and emphasized their views on the company. Quaker Chemical Corporation is a Conshohocken, Pennsylvania-based chemicals company that currently has a $4.2 billion market capitalization. Since the beginning of the year, KWR delivered a -8.03% return, while its 12-month gains are still up by 62.26%. As of March 24, 2021, the stock closed at $233.05 per share.

Here is what Carillon Eagle Small Cap Growth Fund has to say about Quaker Chemical Corporation in their Q4 2020 investor letter:

“Quaker Chemical develops, produces, and markets formulated chemical specialty products. The firm’s shares benefited from the steady stream of positive vaccine developments that led investors to rotate into more cyclical areas of the market. The subsequent improving economic recovery outlook for 2021 should also be a positive for the company’s end markets. Quaker also continues to raise its expected cost synergies from its acquisition of Houghton, which has been an additional tailwind for the firm’s shares.”

Our calculations show that Quaker Chemical Corporation (NYSE: KWR) does not belong in our list of the 30 Most Popular Stocks Among Hedge Funds. As of the end of the fourth quarter of 2020, Quaker Chemical Corporation was in 13 hedge fund portfolios, compared to 16 funds in the third quarter. KWR delivered a -7.68% return in the past 3 months.